Logo image of ENFN

ENFUSION INC - CLASS A (ENFN) Stock Fundamental Analysis

NYSE:ENFN - New York Stock Exchange, Inc. - US2928121043 - Common Stock - Currency: USD

10.76  -0.04 (-0.37%)

After market: 10.76 0 (0%)

Fundamental Rating

6

ENFN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. ENFN has an excellent financial health rating, but there are some minor concerns on its profitability. ENFN is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ENFN was profitable.
In the past year ENFN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ENFN reported negative net income in multiple years.
ENFN had a positive operating cash flow in 4 of the past 5 years.
ENFN Yearly Net Income VS EBIT VS OCF VS FCFENFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

ENFN has a better Return On Assets (1.97%) than 67.61% of its industry peers.
ENFN's Return On Equity of 3.86% is fine compared to the rest of the industry. ENFN outperforms 68.66% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.55%, ENFN is in the better half of the industry, outperforming 73.24% of the companies in the same industry.
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROIC 3.55%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENFN Yearly ROA, ROE, ROICENFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

ENFN's Profit Margin of 1.40% is fine compared to the rest of the industry. ENFN outperforms 65.14% of its industry peers.
In the last couple of years the Profit Margin of ENFN has declined.
With a decent Operating Margin value of 3.05%, ENFN is doing good in the industry, outperforming 68.66% of the companies in the same industry.
In the last couple of years the Operating Margin of ENFN has declined.
Looking at the Gross Margin, with a value of 67.82%, ENFN is in line with its industry, outperforming 52.11% of the companies in the same industry.
ENFN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
ENFN Yearly Profit, Operating, Gross MarginsENFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENFN is destroying value.
ENFN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ENFN has been increased compared to 5 years ago.
There is no outstanding debt for ENFN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ENFN Yearly Shares OutstandingENFN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENFN Yearly Total Debt VS Total AssetsENFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

ENFN has an Altman-Z score of 12.41. This indicates that ENFN is financially healthy and has little risk of bankruptcy at the moment.
ENFN has a Altman-Z score of 12.41. This is amongst the best in the industry. ENFN outperforms 90.49% of its industry peers.
ENFN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.41
ROIC/WACC0.32
WACC11%
ENFN Yearly LT Debt VS Equity VS FCFENFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 3.42 indicates that ENFN has no problem at all paying its short term obligations.
ENFN has a better Current ratio (3.42) than 76.76% of its industry peers.
ENFN has a Quick Ratio of 3.42. This indicates that ENFN is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.42, ENFN is doing good in the industry, outperforming 76.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.42
ENFN Yearly Current Assets VS Current LiabilitesENFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

8

3. Growth

3.1 Past

ENFN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.71%, which is quite impressive.
ENFN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.78% yearly.
ENFN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.51%.
ENFN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.86% yearly.
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%

3.2 Future

Based on estimates for the next years, ENFN will show a very strong growth in Earnings Per Share. The EPS will grow by 27.93% on average per year.
ENFN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.45% yearly.
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ENFN Yearly Revenue VS EstimatesENFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ENFN Yearly EPS VS EstimatesENFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 56.63, the valuation of ENFN can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ENFN is on the same level as its industry peers.
When comparing the Price/Earnings ratio of ENFN to the average of the S&P500 Index (27.30), we can say ENFN is valued expensively.
The Price/Forward Earnings ratio is 37.68, which means the current valuation is very expensive for ENFN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ENFN indicates a somewhat cheap valuation: ENFN is cheaper than 60.56% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ENFN to the average of the S&P500 Index (21.76), we can say ENFN is valued expensively.
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
ENFN Price Earnings VS Forward Price EarningsENFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ENFN indicates a somewhat cheap valuation: ENFN is cheaper than 61.97% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ENFN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 58.73
EV/EBITDA 74.97
ENFN Per share dataENFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ENFN's earnings are expected to grow with 27.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.13
PEG (5Y)N/A
EPS Next 2Y40.46%
EPS Next 3Y27.93%

0

5. Dividend

5.1 Amount

No dividends for ENFN!.
Industry RankSector Rank
Dividend Yield N/A

ENFUSION INC - CLASS A

NYSE:ENFN (4/17/2025, 8:15:24 PM)

After market: 10.76 0 (0%)

10.76

-0.04 (-0.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-03 2025-03-03/amc
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners94.22%
Inst Owner Change0%
Ins Owners3.2%
Ins Owner Change-108.69%
Market Cap1.40B
Analysts50.91
Price Target11.15 (3.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.01%
Min EPS beat(2)-52.94%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-0.65%
Min EPS beat(4)-52.94%
Max EPS beat(4)62.27%
EPS beat(8)2
Avg EPS beat(8)-9.58%
EPS beat(12)5
Avg EPS beat(12)0.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.8%
Min Revenue beat(2)-4.7%
Max Revenue beat(2)-2.9%
Revenue beat(4)0
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-4.7%
Max Revenue beat(4)-1.06%
Revenue beat(8)1
Avg Revenue beat(8)-2.79%
Revenue beat(12)3
Avg Revenue beat(12)-1.79%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)7.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.51%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
P/S 6.93
P/FCF 58.73
P/OCF 40.29
P/B 19.08
P/tB 19.08
EV/EBITDA 74.97
EPS(TTM)0.19
EY1.77%
EPS(NY)0.29
Fwd EY2.65%
FCF(TTM)0.18
FCFY1.7%
OCF(TTM)0.27
OCFY2.48%
SpS1.55
BVpS0.56
TBVpS0.56
PEG (NY)1.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROCE 5.31%
ROIC 3.55%
ROICexc 6.69%
ROICexgc 6.69%
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
FCFM 11.8%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-41.88%
ROICexc growth 3YN/A
ROICexc growth 5Y-41.88%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
F-Score5
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.67%
Cap/Sales 5.4%
Interest Coverage 250
Cash Conversion 193.66%
Profit Quality 842.72%
Current Ratio 3.42
Quick Ratio 3.42
Altman-Z 12.41
F-Score5
WACC11%
ROIC/WACC0.32
Cap/Depr(3y)104.86%
Cap/Depr(5y)147.45%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A
EBIT growth 1Y-48.51%
EBIT growth 3YN/A
EBIT growth 5Y-15.03%
EBIT Next Year76.73%
EBIT Next 3Y40.41%
EBIT Next 5YN/A
FCF growth 1Y49.03%
FCF growth 3YN/A
FCF growth 5Y24.73%
OCF growth 1Y35.3%
OCF growth 3YN/A
OCF growth 5Y23.02%